IBI3005

· Innovent Biologics (Suzhou) Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IBI3005, covering 2025-01-22 to 2025-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Study of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors [Phase 1]